What are the symptoms of Chronic Obstructive Pulmonary Disease (COPD)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Chronic Obstructive Pulmonary Disease (COPD) is characterized by persistent respiratory symptoms, including dyspnea, cough, and/or sputum production, which are the most frequent symptoms, as stated in the 2017 report by the Global Initiative for Chronic Obstructive Lung Disease 1.

Key Symptoms of COPD

The symptoms of COPD can vary, but the most common ones include:

  • Persistent cough with mucus production
  • Shortness of breath, especially during physical activity
  • Wheezing
  • Chest tightness
  • Frequent respiratory infections Many patients also experience fatigue, unintended weight loss, and swelling in the ankles, feet, or legs in advanced stages.

Importance of Early Diagnosis

Early symptoms are often mild and may be mistaken for a cold, but they progressively worsen, particularly if the person continues smoking, as noted in the BTS guidelines for the management of COPD 1.

Underdiagnosis of COPD

The underdiagnosis of COPD in primary care is widespread, with 20% of patients with risk factors for COPD meeting spirometry criteria for moderate, severe, or very severe COPD, as reported in a study published in Chest in 2011 1.

Clinical Diagnosis of COPD

The clinical diagnosis of COPD is suggested by symptoms, but can only be established firmly by an objective measurement indicating airflow obstruction, as stated in the BTS guidelines for the management of COPD 1.

Management of COPD

The goals of COPD management aim to improve symptoms, lung function, and health status and to reduce exacerbations, disease progression, and mortality, as noted in the unified front against COPD: clinical practice guidelines from the American College of Physicians, the American College of Chest Physicians, the American Thoracic Society, and the European Respiratory Society 1. Therefore, it is essential to seek medical evaluation promptly if experiencing symptoms of COPD, particularly smokers or those with occupational exposure to lung irritants, to improve morbidity, mortality, and quality of life outcomes 1.

From the Research

Symptoms of COPD

  • COPD is a respiratory disorder characterized by largely irreversible changes in air flow due to irritants such as tobacco smoke 2
  • Patients with COPD experience acute exacerbations, and severe disease may progress to chronic respiratory failure 2
  • Symptoms of COPD include dyspnea, breathlessness, and acute exacerbations 2, 3, 4

Treatment of COPD

  • Eliminating exposure to cigarette smoke and other irritants is the only measure known to improve the outcome of COPD 2
  • Inhaled short-acting beta-2 agonists, such as salmeterol and formoterol, have been shown to improve dyspnea and reduce breathlessness and acute exacerbations 2, 4
  • Inhaled long-acting antimuscarinic bronchodilators, such as tiotropium, have symptomatic efficacy in COPD, reducing dyspnea and acute exacerbations 2
  • Combination of an antimuscarinic with an inhaled beta-2 agonist improves symptoms in 7% to 10% of patients 2
  • Inhaled corticosteroids, such as beclomethasone, budesonide, or fluticasone, can be added to a long-acting beta-2 agonist to prevent exacerbations 2, 5, 6

Management of COPD Exacerbations

  • Roflumilast, a potent and selective inhibitor of the enzyme phosphodiesterase-4, has been shown to reduce moderate to severe exacerbations in patients with severe COPD 3
  • Formoterol, a highly selective and potent β2-agonist, relaxes airway smooth muscle to significantly improve lung function and reduce symptoms of COPD 4
  • Combination therapy with a long-acting beta2-agonist and an inhaled corticosteroid appears to be effective in improving airway limitation after acute administration in patients with COPD 6

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.